{"id":4346,"date":"2026-06-30T11:28:02","date_gmt":"2026-06-30T15:28:02","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/nephrology\/?p=4346"},"modified":"2026-06-30T11:28:02","modified_gmt":"2026-06-30T15:28:02","slug":"congratulations-professor-lu-on-your-may-2026-promotion","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/nephrology\/2026\/06\/30\/congratulations-professor-lu-on-your-may-2026-promotion\/","title":{"rendered":"Congratulations Professor Lu on your May 2026 Promotion!"},"content":{"rendered":"<p><strong><img loading=\"lazy\" src=\"\/nephrology\/files\/2026\/06\/headshot-from-internet.jpg\" alt=\"weining\" width=\"180\" height=\"168\" class=\"alignnone size-full wp-image-4347\" \/>\u00a0Weining Lu, MD, MS, Medicine\/Nephrology, <\/strong>is a physician-scientist focused on studies of kidney and urinary tract development, disease and novel therapeutics. He has served as the lead academic PI in a highly productive collaboration with Pfizer to develop therapies targeting the SLIT\/ROBO pathway. This academic\u2013industry collaboration led to an international multicenter Phase 2 clinical trial and the first licensing agreement between Pfizer and BU\/BMC. In recognition of this work, Dr. Lu was named the University\u2019s 2019 Innovator of the Year, an award honoring faculty who translate world-class research into inventions and innovations that benefit humankind. Dr. Lu is chair of the Core Oversight Advisory Committee in the department of medicine, co-director of the BU Clinical &amp; Translational Science Institute R01 Proposal Writing Workshop, lead director of the BU Biomedical Innovation Technologies Affinity Research Collaboratives and the B4D-ARC program, and a voting member of the BU Institutional Biosafety Committee. He is a fellow of the American Society of Nephrology and the International Society of Nephrology, a professional member of the American Heart Association, an academic editor for PLOS ONE, and a member of NIH grant review study sections.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0Weining Lu, MD, MS, Medicine\/Nephrology, is a physician-scientist focused on studies of kidney and urinary tract development, disease and novel therapeutics. He has served as the lead academic PI in a highly productive collaboration with Pfizer to develop therapies targeting the SLIT\/ROBO pathway. This academic\u2013industry collaboration led to an international multicenter Phase 2 clinical trial [&hellip;]<\/p>\n","protected":false},"author":24884,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/posts\/4346"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/users\/24884"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/comments?post=4346"}],"version-history":[{"count":1,"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/posts\/4346\/revisions"}],"predecessor-version":[{"id":4348,"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/posts\/4346\/revisions\/4348"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/media?parent=4346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/categories?post=4346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/nephrology\/wp-json\/wp\/v2\/tags?post=4346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}